.jpg "Deepak Balaji T. Govindaraj, nextgeneration health, synthetic biology and precision medicine centre photo")
scientist
CSIR, Gauteng, South Africa
Dr. Deepak Balaji Thimiri Govindaraj is a Centre Manager of CSIR Synthetic Biology and Precision Medicine Centre. Deepak Balaji is a chemical engineer by training and has worked on nanobiotechnology, industrial synthetic biology and drug screening for precision medicine.
During his PhD in KU Leuven Belgium, Deepak worked on Nanobiotechnology methods for cell surface proteomics. The work resulted in a Patent and sold as a product in a spin-out company. Deepak then went to EMBL for a Marie Curie EIPOD Fellow where he designed synthetic baculovirus genome for recombinant protein expression. As a Senior Scientist at Oslo University hospital Norway, Deepak established the drug sensitivity screening platform for blood cancer precision medicine. Deepak has published 32 research papers, 3 granted patents, 25 conference proceedings and book chapters. Deepak has published in high impact journal such as Molecular Systems Biology, Blood, Nanoconvergence and Leukemia.
Disclosure information not submitted.
Monday, February 7, 2022
11:50 AM – 12:10 PM